Additions

Concentration

Inhibition (%)

Qo site antagonist

Myxothiazol

(25 μM)

87.1 ± 1.2

Stigmatellin

(10 μM)

90.6 ± 0.3

Qi site antagonist

Antimycin A

(0.1 μM)

65.3 ± 4.4

Ubiquinone 0

(25 μM)

98.3 ± 0.4

Decylubiquinone

(50 μM)

33.5 ± 2.1